GLAXO stock news
This page provides real-time market news, earnings updates, and company announcements related to GlaxoSmithKline Pharmaceuticals Limited (GLAXO).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-19 22:50 IST
2025's Business Landscape: Strategic Shifts Across Industries Transform Market Dynamics
Bitget-RWA2025-11-22 16:12:18
SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-04 21:24:44
Mr. Duan has also invested in AI
金融界2026-03-11 10:21:44
Candel Therapeutics Reports Extended Survival Tail Observed in Trial of Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors
Finviz2026-03-17 12:09:49
According to a document submitted to the U.S. Securities and Exchange Commission, biotechnology company Regenxbio Inc has confirmed that it will continue, under its existing sublicensing agreement with pharmaceutical giant GlaxoSmithKline, to pay the latter the relevant amounts received from sublicensees.
老虎证券2026-03-20 21:33:00
According to the latest filing from the U.S. Securities and Exchange Commission (SEC), biotechnology company Regenxbio Inc has officially signed a settlement and release agreement with pharmaceutical giant GlaxoSmithKline.
老虎证券2026-03-20 21:33:32
Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer
Finviz2026-03-25 12:03:57
TuHURA Biosciences Appoints Amanda Garofalo, MSHS, as Senior Vice President of Clinical Operations
Finviz2026-04-07 11:48:47
According to a document submitted to the U.S. Securities and Exchange Commission, biotechnology company Regenxbio Inc has confirmed that it will continue, under its existing sublicensing agreement with pharmaceutical giant GlaxoSmithKline, to pay the latter the relevant amounts received from sublicensees.
老虎证券2026-03-20 21:33:00
According to the latest filing from the U.S. Securities and Exchange Commission (SEC), biotechnology company Regenxbio Inc has officially signed a settlement and release agreement with pharmaceutical giant GlaxoSmithKline.
老虎证券2026-03-20 21:33:32
Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer
Finviz2026-03-25 12:03:57
TuHURA Biosciences Appoints Amanda Garofalo, MSHS, as Senior Vice President of Clinical Operations
Finviz2026-04-07 11:48:47
GLAXO stock price change
On the last trading day, GLAXO stock closed at 2453.90 INR, with a price change of 1.41% for the day.
Trade stock perpsGLAXO stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more